US generic drug pricing is a significant variable determining the lucrativeness of the market.
The report covers only US generic drugs and captures its Month-on-Month price change for the last 12 month for various dosage forms.
The price reflects NADAC pricing as reported by Centre for Medicare and Medicaid Studies.